MANILA – The chairman of the Campaign Committee on Good Government and Public Accountability on Sunday said that the joint investigation of the controversy surrounding the previous administration's purchase of dengue vaccine, PHP3.5 billion, Dengvaxia, was scheduled for 20 and 21 November.
In an interview, Camiguin Rep said. Xavier Romualdo that the committee will still comfort other concerns and concerns regarding Dengvaxia mess.
"Hopefully we will be able to tie up loose ends and get a more complete picture of why and how the government got the vaccines and rolled out the vaccination program and crimes were committed by the officials involved in the process," said Romualdo.
He noted that the panel will complete the committee report that has not yet been approved when it was previously headed by Surigao del Sur Johnny Pimentel.
The House Committee for Good Government and Public Accountability held several joint hearings on the controversial anti-dengue vaccine with the Household Committee on Health, Chairman of Quezon Rep. Angelina Tan.
Under President Benigno Aquino III, the Philippines became the first country in the world to launch a public inoculation plan against dengue in April 2016.
The Ministry of Health has since suspended anti-dengue immunization surgery after the drug company Sanofi Pasteur said that Dengvaxia could exacerbate the symptoms of vaccinated children who first hit the disease.
More than 700,000 Philippine schoolchildren had already received their Dengvaxia shots when DOH suspended the immunization operation. (PNA)